Toshikazu Miyakawa

Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh et al. · Journal of Virology · 2004 · 221 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Structural and Molecular Interactions of CCR5 Inhibitors with CCR5

Kenji Maeda, Debananda Das, Hiromi Ogata-Aoki et al. · Journal of Biological Chemistry · 2006 · 162 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5

Kenji Maeda, Kazuhisa Yoshimura, Shiro Shibayama et al. · Journal of Biological Chemistry · 2001 · 126 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Potent Anti-R5 Human Immunodeficiency Virus Type 1 Effects of a CCR5 Antagonist, AK602/ONO4128/GW873140, in a Novel Human Peripheral Blood Mononuclear Cell Nonobese Diabetic-SCID, Interleukin-2 Receptor γ-Chain-Knocked-Out AIDS Mouse Model

Hirotomo Nakata, Kenji Maeda, Toshikazu Miyakawa et al. · Journal of Virology · 2005 · 57 citations · Full text

Life Sciences, Immunology, Pharmacology +11

Switching Tenofovir/Emtricitabine plus Lopinavir/r to Raltegravir plus Darunavir/r in Patients with Suppressed Viral Load Did Not Result in Improvement of Renal Function but Could Sustain Viral Suppression: A Randomized Multicenter Trial

Takeshi Nishijima, Hiroyuki Gatanaga, Takuro Shimbo et al. · PLoS ONE · 2013 · 37 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17